Breaking News, Collaborations & Alliances

ABL Enters Seven-year Multimillion Dollar Contract with NIH

Will support product development processes, documentation and production of customized recombinant proteins and monoclonal antibodies.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Advanced BioScience Laboratories (ABL), a global contract development and manufacturing organization (CDMO) and contract research organization (CRO) serving the U.S. Government and biopharmaceutical industry, was awarded an Indefinite Delivery, Indefinite Quantity (IDIQ) contract by the National Institute of Allergy and Infectious Diseases (NIAID) Division of Microbiology and Infectious Diseases (DMID) of the National Institutes of Health (NIH), under the Diagnostics Preclinical Services program...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters